WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. LIKE US ON FACEBOOK. FOLLOW US ON INSTAGRAM & TWITTER. SUBSCRIBE TO OUR YOUTUBE. What that specialty status will actually mean for the […]
On Air
-
Mushroom Mania: 2022’s Trendy Plant Boasts Major Health Benefits
-
Dr. James Taylor l The Carl Nelson Show
-
WATCH: What You Need To Know — January 12, 2022: Biden’s True Test — RNC Pays Trump Bills — Black and Missing
-
WATCH: What You Need To Know — November 13, 2020: Biden Gaining Acceptance — Sterling Brown Settles $750K Lawsuit — New Obama Memoir
